Zoetis
Trade Zoetis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ZTS
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.
ZTS Key Statistics
Stock Snapshot
With a market cap of 33.45B, Zoetis(ZTS) trades at $80.97. The stock has a price-to-earnings ratio of 13.33 and currently yields dividends of 2.58%.
During the trading session on 2026-10-26, Zoetis(ZTS) shares reached a daily high of $81.19 and a low of $80.10. At a current price of $80.97, the stock is +1.1% higher than the low and still -0.3% under the high.
Trading volume for Zoetis(ZTS) stock has reached 2.85M, versus its average volume of 3.85M.
The stock's 52-week range extends from a low of $68.77 to a high of $147.93.
The stock's 52-week range extends from a low of $68.77 to a high of $147.93.
ZTS News
Advertisement FDA approval for Convenia RTU puts Zoetis in focus Zoetis (ZTS) received FDA approval for Convenia RTU for Dogs, a single-dose injectable antibi...
Zoetis reported that the FDA has approved Convenia RTU for Dogs, a more concentrated cefovecin injectable that provides up to 14 days of treatment for susceptib...
Zoetis (NYSE:ZTS) received FDA approval for Convenia RTU for Dogs, a long acting injectable antibiotic for canine skin infections. The new formulation is more...
Analyst ratings
72%
of 18 ratingsMore ZTS News
In the latest close session, Zoetis (ZTS Quick QuoteZTS - Free Report) was down 1.18% at $81.03. The stock trailed the S&P 500, which registered a daily l...
Zoetis Inc. (ZTS Quick QuoteZTS - Free Report) and ImmuCell Corporation (ICCC Quick QuoteICCC - Free Report) operate in the animal health industry b...
Zoetis (ZTS) announced that the U.S. FDA has approved Convenia RTU for Dogs for the treatment of susceptible bacterial skin infections in dogs. For many familie...
Jefferies analyst Keith Devas downgraded Zoetis (ZTS) to Hold from Buy with a price target of $83, down from $103. The firm cites the company’s softer pricing e...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.